Study design
heart failure, PPCM
HEART FAILURE
From 2017 to 2021, we enrolled 25 consecutive, consenting patients with PPCM that presented to our dedicated heart failure clinic at Groote Schuur Hospital (GSH) and the University of Cape Town (UCT). In this single-centre, prospective clinical trial, patients were randomized to receive either 24 h-Holter monitoring plus an implantable loop recorder (ILR) (Study flow. Ethical approval was obtained from the Human Research Ethics Committee (HREC) at UCT (HREC Ref. 178/2014) and the trial was registered with the Pan African Clinical Trials Registry (PACTR202104866174807). The study was performed in accordance with the Declaration of Helsinki and all patients provided written informed consent prior to study inclusion.